Royalties to NeoPharm Sample Clauses

Royalties to NeoPharm. (a) In consideration for NK’s sublicensing and licensing of the Licensed Technology in the Territory, NK shall pay to NeoPharm a royalty (the “Royalty”) on all Net Sales of Products in the Territory at the rate of [*] percent [*]% commencing with the First Commercial Sale of a Product in the Territory and continuing for the balance of the Term, as defined in Section 11.1. During any Additional Term, as defined in Section 11.1, NK shall pay a Royalty on all its Net Sales of Products in the Territory at the rate of [*] percent [*]%; provided, however, that, if any Valid Claim of Licensed Patent Rights in the Territory exists during the Additional Term, the rate shall be [*] percent [*]%until all of the Valid Claim of Licensed Patent Rights in the Territory cease to exist. Following the expiration of NK’s obligations to pay Royalties to NeoPharm, NK shall have no further rights under this Agreement or otherwise to research, develop, use, sell, offer for sale, promote or import IL13 and/or Product in the Territory and all such rights shall immediately revert exclusively to NeoPharm.
Sample 1Sample 2
AutoNDA by SimpleDocs

Related to Royalties to NeoPharm

  • Royalties on Net Sales Novo will pay to Neose royalties as a percentage of annual Net Sales of each New Product during the Term at the applicable rates set forth in this Section 4.1 and in accordance with this Section 4:

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Royalties 8.1 In consideration of the license herein granted, LICENSEE shall pay royalties to LICENSOR as follows:

  • Third Party Royalties Each party shall be responsible for all of its own costs of commercializing Products or licensing Intellectual Property Rights, including any payments to Third Parties for work done by such Third Parties or for licenses necessary for the manufacture, sale, or use of Products by a party or its Affiliates or sublicensees.

  • Royalty 8.1 In consideration of the rights granted under clause 2, the Licensee shall pay to the Licensor royalties, on each twelve month time period, first calculated from the date of execution of this Agreement, and calculated on a scale as follows:

  • Royalty Payments (i) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate.

  • Sublicense (a) The license granted in Paragraph 2.1 includes the right of LICENSEE to grant Sublicenses to third parties during the Term but only for as long as the license to Patent Rights is exclusive.

  • Sublicense Grant Licensee will be entitled to grant Sublicenses to third parties under the license granted pursuant to Section 2.1 subject to the terms of this Section 2.3. Any such Sublicense shall be on terms and conditions in compliance with and not inconsistent with the terms of this Agreement. The grant of a Sublicense shall not in any way diminish or alter Licensee’s obligations under this Agreement.

  • Earned Royalties Subject to of Article 7 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to one and [*****] of the Net Invoice Value of Trademarked Products Sold by Licensee (the "Royalties"). The Royalties shall be remitted in accordance with Section 7.4 of this Agreement. 6.2

Time is Money Join Law Insider Premium to draft better contracts faster.